Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy

Integrase-defective lentiviral vectors (IDLVs) have been used as a safe and efficient delivery system in several immunization protocols in murine and non-human primate preclinical models as well as in recent clinical trials. In this work, we validated in preclinical murine models our vaccine platfor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Viruses
Hlavní autoři: Morante, Valeria, Borghi, Martina, Farina, Iole, Michelini, Zuleika, Grasso, Felicia, Gallinaro, Alessandra, Cecchetti, Serena, Di Virgilio, Antonio, Canitano, Andrea, Pirillo, Maria Franca, Bona, Roberta, Cara, Andrea, Negri, Donatella
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927015/
https://ncbi.nlm.nih.gov/pubmed/33672349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13020355
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky